|
Bio Expo Online / Allied Services / Process Analytical Development
Aceto Corporation
New York
United States
Aceto Corporation distributes over 1,000 chemicals in these and other fields. Company strengths include unparalleled global sourcing capabilities, regulatory support for our suppliers and customers, and a top notch sales and distribution organization.
Aesica Pharmaceuticals Limited
United Kingdom
Our state-of-the-art technology offers the capability to manufacture development compounds in quantities for use in Phase I to III clinical trials or for high volume continuous supplies. We will carry out all your IND/CMC requirements from the preclinical stage right through to commercial supply.
Alphora Research, Inc
Canada
Alphora's API development efforts focus from the medicinal chemistry stage of lead optimization through to phase III clinical trials. This focus includes: Synthetic scale-up development; Analytical development and validation; Stability testing; Gram to kilogram synthesis, both cGMP and non-GMP; Technology transfer services.
Aptuit, Inc.
Kansas
United States
EPPS offers CMC focused, complete API development from preclinical to commercial phases.
Ash Stevens, Inc.
Michigan
United States
To meet your outsourcing needs, Ash Stevens offers a comprehensive and flexible package of manufacturing services to support early-stage development, FDA registration, and commercialization.
Barnstead International
Iowa
United States
Boulder Scientific Company
Colorado
United States
BSC emphasizes customer relationships in all its markets, which include bulk Grignard reagents, specialty silanes, phosphines, borates, organometallic compounds of zirconium, titanium, hafnium,
and nickel, pharmaceutical reagents, and products from laboratory scale up to full manufacturing scale.
Cambrex
New Jersey
United States
Cambrex’s offerings include Controlled Substances, High Potency/Cytotoxics, High Energy, Polymeric Drug Delivery, Biocatalysis/Biotransformation, Chiral Synthesis, Hydrogenation, and Nitration.
Cambridge Major Laboratories, Inc.
Wisconsin
United States
The company just completed a major renovation of it's BudgetFTE facilty which is now open for business. Expertise includes heterocycles, oxazoles, phenazines,indoles, tryptohanes, furanes, biphenyls, fluorenes, organo-metallic chemistry, palladium and nickel-catalyzed reactions, nucleosides, sugars, nucleotide reagents, amino acids, and a range of chiral chemistries.
Chemcon America, Inc.
Florida
United States
Chemizon Inc.
Colorado
United States
Chemizon's technical expertise, coupled with a flexible business model that ranges from fee-for-service to value participation, has been instrumental in its rapid growth in the drug discovery space. In addition to drug discovery capabilities, Chemizon also provides route development and synthesis expertise to its pharmaceutical industry partners. Headquartered in Korea and with operations in China and the US, Chemizon was founded in 2005 and is privately held.
deCODE Chemistry & BioStructures
Illinois
United States
deCODE provides its customers with a complete solution for discovering and developing optimized clinical candidates in a timely and cost-efficient manner.
Delmar Chemicals Inc.
Canada
Delmar offers a full range of custom development and manufacturing services performed under Confidential Disclosure Agreements. These services include process development and validation, analytical method development and validation, full scale production with stability studies, custom organic synthesis from gram to multi-ton quantities, and complete regulatory documentation including DMF submissions.
Dowpharma
Michigan
United States
Pharmaceutical and fine chemicals companies can contract Dowpharma to manufacture chiral intermediates in either cGMP or non-cGMP assets using its proprietary technology, or directly purchase catalysts and operate the process in the facilities of their choice. In addition, Dowpharma can offer products produced through its preferred Asian contract manufacturing network.
Euticals Prima European Therapeuticals
Italy
EUTICALS and PROCHISA satisfy exclusive productions proposals with sophisticated process technologies. All companies of Euticals group have their own product list intended for generics and free markets and they meet any type of regulatory requirement.
Gland Pharma Limited
India
Gland Pharma has pioneered Heparin technology in India and has a position of leadership in the Glycosaminoglycans (GAGs) range of molecules. Gland also manufactures and markets its own products.
Hamari Chemicals, Ltd.
Japan
Hamari has the ability to produce from pilot plant scale to commercial scale and to minimize the period from development to validation, while providing you with a confidentiality agreement prior to any transfer of proprietary information, making the transition from the developmental phase to commercial phase as smooth as possible.
Hauser Pharmaceutical Services
Colorado
United States
We also develop needed analytical methods, provide process development and optimization, prepare and characterize standards, and perform stability testing and impurity studies under strict cGMP guidelines in a FDA registered facility.
Inogent Laboratories Private Limited
India
Medichem S.A.
Spain
Medichem provides integrated services to help our clients reduce the time, costs and risks associated with drug development.
Omegachem Inc
Canada
Omnichem
Belgium
Park Place Research
United Kingdom
Patheon Inc.
Canada
Patheon’s comprehensive range of integrated Pharmaceutical Development Services (PDS) are offered from five dedicated development Centers of Excellence. Our Quick to Clinic™ programs are exclusively focused on rapidly accelerating your early phase development projects to First Time In Human (FTIH) studies while conserving your valuable active pharmaceutical ingredients (API).
PCI Synthesis
Massachusetts
United States
PCI Synthesis has the proven ability to navigate the regulatory processes. The company is harmonized to the ICH guidelines and is Part 11 7a compliant.
PharmaZell GmbH
Germany
PII Pharmaceutics International Inc.
Maryland
United States
Polymer Chemistry
Arizona
United States
PPG Fine Chemicals
Pennsylvania
United States
PPG Fine Chemicals has expanded its phosgene derivatives capabilities and technology at its LaPorte, Texas facility targeting the pharmaceutical area, but with application to the agricultural intermediates as well. A new cGMP manufacturing facility and a specialty isocyanate unit in LaPorte began operation in 2000.
Prosonix Ltd.
United Kingdom
<< prev 1 2 next >>
|